Sequence Similarity Clusters for the Entities in PDB 4GAG

Entity #1 | Chains: H
NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN protein, length: 218 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 3 19137
95 % 1 3 17561 Flexibility: Low
Max RMSD: 1.0, Avg RMSD: 0.7
PDBFlex
90 % 3 14 2897
70 % 246 2600 2
50 % 508 5362 1
40 % 628 6051 1
30 % 760 7514 1
Entity #2 | Chains: L
NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN protein, length: 218 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 3 19138
95 % 2 40 822 Flexibility: Low
Max RMSD: 4.9, Avg RMSD: 1.4
PDBFlex
90 % 5 109 153
70 % 243 2637 1
50 % 509 5362 1
40 % 629 6051 1
30 % 761 7514 1
Entity #3 | Chains: P
Genome polyprotein protein, length: 12 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 5IVN 1 A BC2-nanobody 30538
2 5E7B 1 A nanobody nano-L06 9838
3 2P45 2 B ANTIBODY CAB-RN05 9838
4 2X1Q 1 A, B GELSOLIN NANOBODY 9844
5 5U64 1 B VHH-28 9838
6 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 4NZU 1 L 13PL heavy chain Fab 9606
10 4NZU 2 H 13PL light chain Fab 9606
11 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
12 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
13 5IMM 1 B Nanobody 9835
14 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
15 5NLU 1 A single domain llama antibody Nb36 9844
16 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
17 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 1MEX 1 L Fab 29G12 light chain 10090
19 1MEX 2 H Fab 29G12 heavy chain 10090
20 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
21 5IMK 1 B Nanobody 9835
22 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
23 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
25 4BUH 1 A, B CLONE M0418 SCFV 9606
26 4B50 1 A 2H10 LLAMA VHH 9844
27 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
28 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
29 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
30 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
31 6DBA 1 A, B nanobody VHH R303 9838
32 5YD4 1 A, C, E, G scFv 4B08 10090
33 5YD3 1 A, C, E, G scFv 4B08 10090
34 2XT1 2 B CAMELID VHH 9 30538
35 5UD9 1 H Fab heavy chain 9606
36 5UD9 2 L Light chain 9606
37 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
38 4P48 1 A Antibody scFv 180 9031
39 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
40 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
41 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
42 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
43 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
44 5J1S 3 C VHH domain BS-2 30538
45 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
46 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
47 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
48 5J1T 3 C VHH domain BS-2 30538
49 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
50 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
51 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
52 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
53 4XCF 1 L 4E10 Fab light chain 9606
54 4XCF 2 H 4E10 Fab heavy chain 9606
55 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
56 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
57 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
58 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
59 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
60 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
61 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
62 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
63 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
64 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
65 5X08 1 H Fab 4E10 Heavy chain 9606
66 5X08 2 L Fab 4E10 Light chain 9606
67 2X1O 1 A, B GELSOLIN NANOBODY 9844
68 4QGY 1 A, B nanobody n25, VH domain 9844
69 5C2B 1 H scFv 3B4 heavy chain 9606
70 4XAW 1 L 4E10 Fab light chain 9606
71 4XAW 2 H 4E10 Fab heavy chain 9606
72 5VNV 1 A Nb.b201 32630
73 4P49 1 A Antibody scFv B8 9031
74 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
75 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
76 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
77 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
78 5DXW 1 A PD-L1 nanobody 10090
79 5UCB 1 H Fab Heavy Chain 9606
80 5UCB 2 L Fab Light Chain 9606
81 2VXV 1 H HUMAN IGG ABT-325 9606
82 2VXV 2 L HUMAN IGG ABT-325 9606
83 4N9O 2 B Nanobody Nb484 Nb484 9844
84 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
85 4GXV 1 H, I Antibody 1F1, heavy chain 9606
86 4GXV 2 L, M Antibody 1F1, light chain 9606
87 2VXT 1 H MURINE IGG 125-2H 10090
88 2VXT 3 L MURINE IGG 125-2H 10090
89 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
90 1T2J 1 A M12-Variable Heavy domain 9606
91 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
92 6DBF 2 B InlB specific VHH R303 9838
93 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
94 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
95 6DBG 2 C, D VHH R303 9838
96 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
97 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
98 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
99 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
100 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
101 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
102 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
103 5W24 1 L 5C4 Fab Light Chain 10090
104 5W24 2 H 5C4 Fab Heavy Chain 10090
105 4HPY 1 H CH59 Fab heavy chain 9606
106 4HPY 2 L CH59 Fab light chain 9606
107 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
108 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
109 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
110 5VM6 1 A single domain camelid nanobody VHH T10 9844
111 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
112 4JG1 1 L Fab light chain 9606
113 4JG1 2 H Fab heavy chain 9606
114 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
115 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
116 4KML 2 B Nanobody 9844
117 5VF2 1 A scFv 2D10 10090
118 5I8C 1 A VRC34.01 Fab heavy chain 9606
119 5I8C 2 B VRC34.01 Fab light chain 9606
120 4O5L 1 L Fab F045-092 light chain 9606
121 4O5L 2 H Fab F045-092 heavy chain 9606
122 5MYX 1 A, C Fab c#24 light chain 10090
123 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
124 4Z9K 2 B VHH2(F5) antibody 30538
125 3IFL 1 L 12A11 FAB antibody light chain 10090
126 3IFL 2 H 12A11 FAB antibody heavy chain 10090
127 5WK2 1 L M116 LIGHT CHAIN 9606
128 5WK2 2 H M116 HEAVY CHAIN FD 9606
129 3PP4 1 H GA101 Fab heavy chain 10090
130 3PP4 2 L GA101 Fab light chain 10090
131 3KDM 1 A, L Immunoglobulin light chain 9606
132 3KDM 2 B, H Immunoglobulin heavy chain 9606
133 5NIV 1 A Light chain of 5D3 Fab 10090
134 5NIV 2 B Heavy chain of 5D3 Fab 10090
135 5N4J 1 L LIGHT CHAIN 9606
136 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
137 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
138 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
139 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
140 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
141 5X4G 1 A 6H8 Fab heavy chain 10090
142 5X4G 2 B 6H8 Fab light chain 10090
143 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
144 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
145 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
146 4PTU 1 A Antibody pn132p2C05, light chain 9606
147 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
148 4TPR 1 L If kappa light chain 10090
149 4TPR 2 H Fab heavy chain 10090
150 5LMW 1 A Nanobody 9844
151 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
152 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
153 3IFN 1 H 12A11 FAB antibody heavy chain 10090
154 3IFN 2 L 12A11 FAB antibody light chain 10090
155 5U3P 1 H DH511.4 Fab Heavy Chain 9606
156 5U3P 2 L DH511.4 Fab Light Chain 9606
157 6BLA 1 H AMM01 Fab Heavy chain 9606
158 6BLA 2 L AMM01 Fab Light chain 9606
159 5NM0 1 A, B, C, D Nb36 9844
160 4TOY 1 H 35O22 Fab Heavy chain 9606
161 4TOY 2 L 35O22 Fab Light chain 9606
162 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
163 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
164 3NPS 2 B S4 FAB HEAVY CHAIN 9606
165 3NPS 3 C S4 FAB LIGHT CHAIN 9606
166 5I4F 1 A scFv 2D10 10090
167 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
168 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
169 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
170 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
171 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
172 5WN9 1 H scFv 2D10 9606
173 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
174 4XC3 1 L 4E10 Fab light chain 9606
175 4XC3 2 H 4E10 Fab heavy chain 9606
176 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
177 4PPT 1 A Engineered single domain VHH antibody 9844
178 3R0M 1 A, B Llama VHH A12 9844
179 4M5Y 1 H, I Fab 5J8 heavy chain 9606
180 4M5Y 2 L, M Fab 5J8 light chain 9606
181 4TQE 1 L If kappa light chain 10090
182 4TQE 2 H Fab heavy chain 10090
183 3ZKQ 2 D XA4813 9844
184 5YY4 1 A scFv 4B08 10090
185 4I13 2 B Protein ca1697 (nanobody) 9844
186 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
187 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
188 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
189 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
190 5C2U 1 B Nanobody Nanobody 9838
191 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
192 5VSI 2 L CH1/Ckappa Fab light chain 9606
193 1XFP 1 A heavy chain antibody VHH domain 9838
194 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
195 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
196 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
197 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
198 5JXA 1 H VRC03 Heavy chain 9606
199 5JXA 2 L VRC03 Light chain 9606
200 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
201 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
202 4POY 1 A VHH-metal 9844
203 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
204 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
205 5NLW 1 A nanobody Nb36 9844
206 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
207 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
208 3NTC 1 L Fab light chain 10090
209 3NTC 2 H Fab heavy chain 10090
210 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
211 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
212 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
213 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
214 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
215 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
216 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
217 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
218 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
219 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
220 6BE3 1 H Fab (F598) Heavy Chain 9606
221 6BE3 2 L Fab (F598) Light Chain 9606
222 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
223 3G9A 2 B Minimizer 9838
224 4NWU 1 H APE1551 Ab Fab heavy chain 9606
225 4NWU 2 L APE1551 Ab Fab light chain 9606
226 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
227 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
228 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
229 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
230 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
231 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
232 5EWI 1 H VRC38.01 Heavy Chain 9606
233 5EWI 2 L VRC38.01 Light Chain 9606
234 5E2W 1 L AT8 LIGHT CHAIN 10090
235 5E2W 2 H AT8 HEAVY CHAIN 10090
236 5MYK 1 A Fab c#17 light chain 10090
237 5MYK 2 B Fab c#17 heavy chain 10090
238 4NZR 1 H PGT135 heavy chain Fab 9606
239 4NZR 2 L PGT135 light chain Fab 9606
240 5MYO 1 A, C Fab c#6 light chain 10090
241 5MYO 2 B, D Fab c#6 heavy chain 10090
242 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
243 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
244 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
245 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
246 5UEL 1 H 354NC102 Fab Heavy Chain 9606
247 5UEL 2 L 354NC102 Fab Light Chain 9606
248 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
249 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
250 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
251 2P43 2 B ANTIBODY CAB-RN05 9838
252 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
253 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
254 5E2V 1 L AT8 LIGHT CHAIN 10090
255 5E2V 2 H AT8 HEAVY CHAIN 10090
256 4KRN 1 A Nanobody/VHH domain EgA1 9844
257 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
258 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
259 4GFT 2 B Nanobody 9844
260 4TVS 2 a, b VHH Domain BS-1 30538
261 4W6Y 2 B Nanobody NbFedF9 9844
262 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
263 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
264 6EZW 1 B VHH antibody BCD090-M2 9844
265 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
266 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
267 5JUE 1 L light chain of UIC2 Fab 10090
268 5JUE 2 H heavy chain of UIC2 Fab 10090
269 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
270 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
271 1UAC 2 H Ig VH,anti-lysozyme 10090
272 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
273 5JR1 1 H 10E8 heavy chain 9606
274 5JR1 2 L 10E8 mature light chain 9606
275 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
276 6CA7 1 L PCT64_13C light chain 9606
277 6CA7 2 H PCT64_13C heavy chain 9606
278 5VF6 1 A single chain variable fragment 9031
279 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
280 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
281 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
282 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
283 5OB5 2 H fAb Heavy chain 9606
284 5OB5 3 L fAb Light chain 9606
285 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
286 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
287 5I66 1 A 8B6 antibody, heavy chain 10090
288 5I66 2 B 8B6 antibody, light chain 10090
289 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
290 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
291 6BZY 1 H 22D11 Heavy Chain 10090
292 6BZY 2 L 22D11 Light Chain 10090
293 3QQ9 1 C, L 101F LIGHT CHAIN 10090
294 3QQ9 2 D, H 101F HEAVY CHAIN 10090
295 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
296 5TKK 3 L mouse antibody vFP5.01 light chain 10090
297 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
298 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
299 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
300 5W6C 1 H UCA Fab heavy chain 9606
301 5W6C 2 L UCA Fab light chain 9606
302 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
303 5I1K 1 L FAB LIGHT CHAIN 9606
304 5I1K 2 H FAB HEAVY CHAIN 9606
305 3OZ9 1 L Fab NC-1 kappa light chain 10090
306 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
307 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
308 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
309 5V7U 1 L CBTAU-22.1 Fab light chain 9606
310 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
311 5UEA 1 A, H Fab Heavy Chain 9606
312 5UEA 3 B, L Fab Light Chain 9606
313 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
314 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
315 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
316 3G5Y 1 A 175 light chain 10090
317 3G5Y 2 B 175 heavy chain 10090
318 5O02 2 C Nanobody (VHH) Nano-4 30538
319 5NMV 1 L Fab light chain 10088
320 5NMV 2 H Fab heavy chain 10088
321 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
322 4N8C 2 L, M Light chain of monoclonal antibody 10090
323 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
324 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
325 4HGW 1 A Antibody Fab fragment, light chain 10090
326 4HGW 2 B Antibody Fab fragment, heavy chain 10090
327 1NLB 1 L antibody 19D9D6 light chain 10090
328 1NLB 2 H antibody 19D9D6 heavy chain 10090
329 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
330 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
331 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
332 3VFG 1 L 3F8 Light Chain 10090
333 3VFG 2 H 3F8 Heavy Chain 10090
334 4X7F 2 C, D Nano-25 Nanobody 30538
335 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
336 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
337 3QRG 1 L Fab light chain 9606
338 3QRG 2 H Fab heavy chain Fd fragment 9606
339 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
340 5M6A 1 A, B, C, D Bence-Jones light chain 9606
341 4LLY 2 B, D light chain Clambda 9606
342 4LGR 2 B Camelid nanobody (VHH3) 30538
343 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
344 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
345 5EZI 1 H Fab c12 heavy chain 9606
346 5EZI 2 L Fab c12 Light chain 9606
347 4K23 1 H anti-uPAR antibody, heavy chain 10090
348 4K23 2 L anti-uPAR antibody, light chain 10090
349 5J57 2 B VHH single chain antibody V5E1 30538
350 3NCJ 1 L Fab15 Mut8 light chain 9606
351 3NCJ 2 H Fab15 Mut8 heavy chain 9606
352 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
353 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
354 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
355 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
356 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
357 5W05 1 L M59 FAB LIGHT CHAIN 10090
358 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
359 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
360 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
361 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
362 5OMM 2 C Nanobody (VHH) Nano-14 30538
363 5E03 1 A mouse CTLA-4 nanobody 10090
364 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
365 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
366 4M61 1 A, C Fab A52 light chain 10090
367 4M61 2 B, D Fab A52 heavy chain 10090
368 5YE3 1 B 2A7D9 VH CH1 chain 10090
369 5YE3 2 A 2A7D9 L chain 10090
370 5LZ0 1 A, B PorM nanobody 9844
371 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
372 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
373 1UM5 1 L Antibody 21H3 L chain 10090
374 1UM5 2 H Antibody 21H3 H chain 10090
375 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
376 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
377 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
378 4NWT 1 L APE1531 Ab Fab light chain 9606
379 4NWT 2 H APE1531 Ab Fab heavy chain 9606
380 6DBE 1 A, B nanobody VHH R303 9844
381 3WHX 1 A mAb Fab H fragment 10090
382 3WHX 2 B mAb Fab L fragment 10090
383 3NA9 1 L Fab15 light chain 9606
384 3NA9 2 H Fab15 heavy chain 9606
385 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
386 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
387 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
388 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
389 4LRI 1 A, B MSL-109 Light Chain 9606
390 4LRI 2 C, P MSL-109 Heavy Chain 9606
391 2XXC 1 B CAMELID VHH 9 30538
392 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
393 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
394 4JN2 1 A, L anti dabigatran Fab 10090
395 4JN2 2 B, H anti dabigatran Fab 10090
396 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
397 4XBE 2 H 4E10 Fab heavy chain 9606
398 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
399 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
400 6BE2 1 H Fab (F598) Heavy Chain 9606
401 6BE2 2 L Fab (F598) Light Chain 9606
402 3QYC 1 A, B VH domain of IgG molecule 9606
403 4JFZ 1 L Fab light chain 9606
404 4JFZ 2 H Fab heavy chain 9606
405 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
406 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
407 5VAK 2 B Nb914 Nanobody 9844
408 3WIF 1 A mAb Fab H fragment 10090
409 3WIF 2 B mAb Fab L fragment 10090
410 5U6A 1 A Light Chain 9606
411 5U6A 2 B Heavy Chain 9606
412 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
413 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
414 3MBX 1 L X836 LIGHT CHAIN 10090
415 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
416 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
417 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
418 2XXM 2 B CAMELID VHH 9 30538
419 6APC 1 H Epididymis luminal protein 214 9606
420 6APC 2 L IGL@ protein 9606
421 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
422 4HHA 1 A Fab KE5 Fab fragment KE5 9606
423 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
424 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
425 4RGO 2 H 14G8 heavy chain Fab 10090
426 4RGO 3 L 14G8 light chain Fab 10090
427 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
428 5GRY 1 A, G diabody 9606
429 5UEK 2 H Fab 12E Heavy Chain 9606
430 5UEK 3 L Fab 12E Light Chain 9606
431 3NAA 1 L Fab15 Mut5 light chain 9606
432 3NAA 2 H Fab15 Mut5 heavy chain 9606
433 6DBD 1 A, B, C, D nanobody VHH R326 9844
434 1Q0X 1 L Fab 9B1, light chain 10090
435 1Q0X 2 H Fab 9B1, heavy chain 10090
436 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
437 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
438 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
439 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
440 5JDS 1 B Nanobody 9835
441 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
442 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
443 5IK3 2 B, D 1E03 Fab fragment light chain 9606
444 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
445 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
446 5XLI 1 a, b FabL 10090
447 5XLI 2 c, d FabH 10090
448 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
449 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
450 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
451 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
452 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
453 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
454 4WUK 1 H CH65 heavy chain 9606
455 4WUK 2 L CH65 light chain 9606
456 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
457 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
458 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
459 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
460 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
461 5JOP 1 D, L Fab 14.22 light chain 10090
462 5JOP 2 E, H Fab14.22 heavy chain 10090
463 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
464 4HPO 1 H CH58 Fab heavy chain 9606
465 4HPO 2 L CH58 Fab light chain 9606
466 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
467 5UKN 2 L DH522UCA Fab fragment light chain 9544
468 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
469 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
470 5L21 2 B VHH-C2 30538
471 5IT2 1 H heavy chain 9606
472 5IT2 2 L light chain 9606
473 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
474 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
475 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
476 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
477 5FWO 1 A NANOBODY 9844
478 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
479 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
480 5MO3 3 L Fab of monoclonal antibody, light chain 10090
481 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
482 5GZ0 1 A, C FM329 light chain 1383439
483 5GZ0 2 B, D FM329 heavy chain 1383439
484 6DW2 1 A 6078 Fab light chain 9606
485 6DW2 2 B 6078 Fab heavy chain 9606
486 3B9V 1 A, B, C, D heavy chain variable domain 9606
487 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
488 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
489 6BQB 1 L MGG4 Fab light chain 9606
490 6BQB 2 H MGG4 Fab heavy chain 9606
491 4PUB 1 H DX-2930 HEAVY CHAIN 9606
492 4PUB 2 L DX-2930 LIGHT CHAIN 9606
493 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
494 6B14 2 L Light chain of Fab BL3-6S97N 10090
495 5N88 1 A, H VH59 antibody 9606
496 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
497 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
498 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
499 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
500 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
501 5GS3 1 A, H diabody protein 9606
502 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
503 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
504 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
505 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
506 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
507 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
508 5VKD 2 H Fab Heavy Chain 9606
509 5VKD 3 L Fab light chain 9606
510 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
511 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
512 5XHG 1 A, C polypeptide(L) 10090
513 5XHG 2 B, D polypeptide(H) 10090
514 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
515 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
516 3UYR 1 H antibody Fab heavy chain 10090
517 3UYR 2 L antibody Fab light chain 10090
518 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
519 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
520 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
521 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
522 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
523 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
524 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
525 3OAZ 2 K, L Fab 2G12, light chain 9606
526 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
527 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
528 1ZAN 1 L Fab AD11 Light Chain 10116
529 1ZAN 2 H Fab AD11 Heavy Chain 10116
530 6CJK 1 A, C Immunoglobulin Fab light chain 9986
531 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
532 4N0Y 1 H IGH526 Heavy Chain 9606
533 4N0Y 2 L IGH526 Light Chain 9606
534 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
535 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
536 5MTH 1 A, H antibody Fab heavy chain 10090
537 5MTH 2 B, L antibody Fab light chain 10090
538 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
539 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
540 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
541 1RZF 1 L Fab E51 light chain 9606
542 1RZF 2 H Fab E51 heavy chain 9606
543 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
544 4KTE 2 L GE148 Light Chain Fab 9544
545 5I8O 1 H HMM5 antibody heavy chain 9606
546 5I8O 2 L HMM5 antibody light chain 9606
547 4OUO 1 A anti Bla g 1 scFv 9031
548 4JG0 1 L Fab light chain 9606
549 4JG0 2 H Fab heavy chain 9606
550 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
551 4YGV 2 B, L aDabi-Fab2a light chain 9606
552 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
553 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
554 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
555 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
556 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
557 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
558 3EO0 1 A, C GC-1008 Fab Light Chain 10090
559 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
560 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
561 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
562 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
563 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
564 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
565 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
566 4POU 2 B VHH Antibody 9844
567 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
568 4FQI 3 H antibody CR9114 heavy chain Fab 9606
569 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
570 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
571 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
572 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
573 4JHA 2 L D25 light chain 9606
574 6B9Z 1 A Trastuzumab Fab light chain 10090
575 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
576 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
577 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
578 4PTT 1 A Antibody pn132p2C05, light chain 9606
579 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
580 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
581 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
582 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
583 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
584 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
585 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
586 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
587 2P42 2 B, D ANTIBODY CAB-RN05 9838
588 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
589 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
590 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
591 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
592 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
593 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
594 4DGV 1 H HCV1 Heavy Chain Fab 9606
595 4DGV 2 L HCV1 Light Chain 9606
596 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
597 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
598 5TH2 1 A, C cetuximab Fab, light chain 10090
599 5TH2 2 B, D cetuximab Fab, heavy chain 10090
600 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
601 5I8K 1 L HHH1 Fab Light chain 9606
602 5I8K 2 H HHH1 Fab Heavy chain 9606
603 4QLR 1 A, B Llama nanobody n02 VH domain 9844
604 5J56 2 B VHH single chain antibody V1C7 30538
605 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
606 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
607 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
608 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
609 1YNL 1 L Ig gamma light chain 10090
610 1YNL 2 H Ig gamma heavy chain 10090
611 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
612 5EPM 2 B, F Antibody Fab fragment light chain 10090
613 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
614 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
615 3UMT 1 A scFv heavy chain and light chain 10090
616 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
617 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
618 4NUJ 1 A PGT152 light chain 9606
619 4NUJ 2 B PGT152 heavy chain 9606
620 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
621 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
622 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
623 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
624 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
625 3U2S 2 B, L PG9 light chain 9606
626 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
627 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
628 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
629 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
630 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
631 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
632 4NUG 1 L PGT151 light chain 9606
633 4NUG 2 H PGT151 heavy chain 9606
634 3IU4 1 H chP3 Fab heavy chain 10090
635 3IU4 2 L chP3 Fab light chain 10090
636 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
637 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
638 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
639 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
640 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
641 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
642 1P7K 1 A, L antibody light chain FAB 10090
643 1P7K 2 B, H antibody heavy chain FAB 10090
644 4NBX 2 B A20.1 VHH 9844
645 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
646 3RVV 2 C 4C1 - light chain 10090
647 3RVV 3 D 4C1 - heavy chain 10090
648 4HEP 2 G vHH17 domain 9844
649 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
650 3P0Y 2 H Fab DL11 heavy chain 9606
651 3P0Y 3 L Fab DL11 light chain 9606
652 4NPY 1 A, L germline PGT121 light chain Fab 9606
653 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
654 6ANA 2 H LL2 Fab Heavy Chain 10090
655 6ANA 3 L LL2 Fab Light Chain 10090
656 5IBU 1 B, L 6652 Light Chain 9606
657 5IBU 2 G, H 6652 Heavy Chain 9606
658 5VPL 2 C 4C1 - LIGHT CHAIN 10090
659 5VPL 3 D 4C1 - HEAVY CHAIN 10090
660 6AOD 1 A FXIa Antibody FAB Light Chain 9606
661 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
662 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
663 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
664 2YPV 2 H FAB 12C1 10090
665 2YPV 3 L FAB 12C1 10090
666 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
667 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
668 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
669 4JY5 1 L PGT122 light chain Fab 9606
670 4JY5 2 H PGT122 heavy chain Fab 9606
671 6ELE 1 A, H fAB heavy chain 9606
672 6ELE 2 B, L fAB light chain 9606
673 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
674 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
675 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
676 6B5R 1 H CIS42 Fab Heavy chain 9606
677 6B5R 2 L CIS42 Fab Light chain 9606
678 5IML 2 B Nanobody 9835
679 3NAC 1 L Fab15 Mut7 light chain 9606
680 3NAC 2 H Fab15 Mut7 heavy chain 9606
681 3A6C 2 H IG VH, anti-lysozyme 10090
682 2DQD 2 H Ig VH,anti-lysozyme 10090
683 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
684 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
685 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
686 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
687 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
688 1Q72 1 L Fab M82G2, Light chain 10090
689 1Q72 2 H Fab M82G2, Heavy chain 10090
690 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
691 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
692 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
693 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
694 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
695 4YHO 1 H aDabi-Fab3 heavy chain 9606
696 4YHO 2 L aDabi-Fab3 light chain 9606
697 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
698 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
699 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
700 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
701 4DGY 1 H HCV1 Heavy Chain Fab 9606
702 4DGY 2 L HCV1 Light Chain 9606
703 3A67 2 H IG VH, anti-lysozyme 10090
704 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
705 5EN2 1 A GD01 heavy chain 10090
706 5EN2 2 B GD01 light chain 10090
707 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
708 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
709 1J1X 2 H Ig VH,anti-lysozyme 10090
710 5M2J 2 D Anti-(ED-B) scFV 9606
711 3MXW 2 L 5E1 light chain 9606
712 3MXW 3 H 5E1 heavy chain 9606
713 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
714 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
715 2DQC 2 H Ig VH,anti-lysozyme 10090
716 1J1O 2 H Ig VH,anti-lysozyme 10090
717 3EO9 1 L Efalizumab Fab fragment, light chain 9606
718 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
719 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
720 4M62 2 H, I GEP2 FV heavy chain 9606
721 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
722 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
723 5IVO 1 A BC2-nanobody 30538
724 1J1P 2 H Ig VH,anti-lysozyme 10090
725 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
726 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
727 4NBZ 2 B, D A26.8 VHH 9844
728 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
729 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
730 5WUV 1 L light chain 9606
731 5WUV 2 H heavy chain 9606
732 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
733 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
734 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
735 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
736 5AYU 2 H Ig VH,anti-lysozyme 10090
737 4JM4 1 H PGT 135 Heavy Chain Fab 9606
738 4JM4 2 L PGT 135 Light Chain Fab 9606
739 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
740 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
741 3A6B 2 H IG VH, anti-lysozyme 10090
742 2DQJ 2 H Ig VH,anti-lysozyme 10090
743 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
744 5YE4 2 B, D 1A9D7 L chain 10090
745 5F21 2 B nanobody MU375 9844
746 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
747 6B0G 1 C 1245 Antibody, Light Chain 9606
748 6B0G 2 D 1245 Antibody, Heavy Chain 9606
749 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
750 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
751 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
752 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
753 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
754 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
755 6D0X 1 A 2140 Antibody, heavy chain 9606
756 6D0X 2 B 1210 Antibody, light chain 9606
757 2P44 2 B ANTIBODY CAB-RN05 9838
758 6BE4 1 H Fab (F598) Heavy Chain 9606
759 6BE4 2 L Fab(F598) Light Chain 9606
760 5TPP 1 L DH270.5 Fab heavy chain 9606
761 5TPP 2 H DH270.5 Fab light chain 9606
762 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
763 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
764 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
765 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
766 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
767 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
768 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
769 5TP3 1 A, B F-VHH-4 9844
770 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
771 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
772 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
773 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
774 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
775 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
776 5TL5 1 L M2177 LIGHT CHAIN 10090
777 5TL5 2 H M2177 HEAVY CHAIN 10090
778 2FX7 1 L Fab 4E10 Light Chain 9606
779 2FX7 2 H Fab 4E10 Heavy Chain 9606
780 5Y9K 1 L belimumab light chain 9606
781 5Y9K 2 H belimumab heavy chain 9606
782 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
783 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
784 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
785 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
786 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
787 4LHJ 2 B Camelid antibody 30538
788 3WFH 1 A mAb Fab H fragment 10090
789 3WFH 2 B mAb Fab L fragment 10090
790 4BEL 2 D, E XA4813 9844
791 5M7Q 1 A, B Nanobody NbD2 9838
792 5H8D 1 A VHH nanobody 9844
793 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
794 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
795 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
796 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
797 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
798 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
799 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
800 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
801 3DUR 2 B, D Ig-like protein 10090
802 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
803 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
804 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
805 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
806 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
807 5HI4 3 D, L CAT-2000 FAB light chain 9606
808 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
809 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
810 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
811 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
812 3RVW 2 C 4C1 - light chain 10090
813 3RVW 3 D 4C1 - heavy chain 10090
814 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
815 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
816 5XKU 2 B HNIgGA6 light chain 9606
817 5XKU 3 C HNIgGA6 heavy chain 9606
818 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
819 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
820 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
821 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
822 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
823 5HI5 3 D, L CAT-2000 light chain 9606
824 5JO5 1 A, C, E, H 10E8 gHV 9606
825 5JO5 2 B, D, F, L 10E8 gLV 9606
826 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
827 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
828 2XV6 2 B, D CAMELID VHH 9 30538
829 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
830 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
831 5CCK 2 L Antibody 3BC315 Fab light chain 9606
832 5VM0 1 A, B Camelid Nanobody VHH T9 9844
833 5I76 1 A, C FM318_light_chain 1383439
834 5I76 2 B, D FM318_heavy_cahin 1383439
835 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
836 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
837 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
838 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
839 5I18 1 L FAB LIGHT CHAIN 9606
840 5I18 2 H FAB HEAVY CHAIN 9606
841 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
842 4JN1 2 L anti-dabigatran Fab1, light chain 10090
843 4ZG1 1 A, B, C, D, E, F NB17 9844
844 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
845 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
846 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
847 4G5Z 2 L canakinumab antibody fragment light chain 9606
848 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
849 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
850 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
851 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
852 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
853 2OK0 2 L Fab ED10 light chain 10090
854 2OK0 3 H Fab ED10 heavy chain 10090
855 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
856 3SOB 1 L antibody light chain 9606
857 3SOB 3 H antibody heavy chain 9606
858 6B5M 1 H CIS43 Fab Heavy chain 9606
859 6B5M 2 L CIS43 Fab Light chain 9606
860 4I1N 2 B Protein ca1697 (nanobody) 9844
861 5AWN 1 H Heavy chain of 3BC176 Fab 9606
862 5AWN 2 L Light chain of 3BC176 Fab 9606
863 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
864 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
865 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
866 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
867 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
868 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
869 5DR5 2 L AbD09097 Fab light chain 9606
870 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
871 2IH3 1 A FAB Heavy Chain 10090
872 2IH3 2 B FAB Light Chain 10090
873 4KQ3 1 L CNTO3186 light chain Fab 9606
874 4KQ3 2 H CNTO3186 heavy chain Fab 9606
875 6F0D 1 A, B VHH antibody BCD090-M2 9844
876 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
877 6AQ7 3 L POM6 FAB light CHAIN 10090
878 4JFX 1 A, L Fab light chain 9606
879 4JFX 2 B, H Fab heavy chain 9606
880 3SGE 1 I, L Light Chain 10090
881 3SGE 2 H, J Heavy Chain 10090
882 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
883 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
884 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
885 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
886 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
887 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
888 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
889 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
890 5FHB 1 H Antibody 100 Fab heavy chain 9606
891 5FHB 2 L Antibody 100 Fab light chain 9606
892 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
893 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
894 1JGU 1 L Antibody Light Chain 10090
895 1JGU 2 H Antibody Heavy Chain 10090
896 4I77 1 H Lebrikizumab heavy chain Fab 9606
897 4I77 2 L Lebrikizumab light chain Fab 9606
898 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
899 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
900 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
901 4O4Y 2 H 2095-2 heavy chain 9986
902 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
903 5OBF 1 H fAb Heavy chain 10090
904 5OBF 2 L fAb Light chain 10090
905 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
906 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
907 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
908 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
909 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
910 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
911 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
912 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
913 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
914 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
915 5MHE 1 L Fab-fragment 10090
916 5MHE 2 H Fab-fragment 10090
917 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
918 4GLR 3 I, K anti-ptau light chain light chain 9031
919 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
920 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
921 4HJG 1 A Trastuzumab light chain 9606
922 4HJG 2 B Trastuzumab heavy chain 9606
923 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
924 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
925 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
926 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
927 5I30 1 L Fab PL-2 light chain 10090
928 5I30 2 H Fab PL-2 heavy chain 10090
929 4W6X 2 B Nanobody NbFedF7 9844
930 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
931 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
932 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
933 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
934 3FN0 1 L Fab Z13e1 light chain 9606
935 3FN0 2 H Fab Z13e1 heavy chain 9606
936 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
937 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
938 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
939 4YHI 2 B, L aDabi-Fab2a light chain 9606
940 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation